Factors Affecting Hemoglobin A1c Values
            Siemens Healthcare Global Website


Factors Affecting Hemoglobin A1c Values

Please select an option below:

> US participants please click here to register or login

> International participants (outside U.S.) please click here to register or login


Trefor N. Higgins
Director, Clinical Chemistry - DynaLIFEDx
Clinical Professor, Department of Laboratory Medicine and Pathology - University of Alberta

According to the World Health Organization, more than 220 million people worldwide have diabetes, and this number is likely to more than double by 2030 without intervention. Diabetes is the seventh leading cause of death worldwide as reported by the American Diabetes Association. Hemoglobin A1c is recognized as effective in monitoring long- term glycemic control for improved diabetes management. While clinical assessment of hemoglobin A1c values is critical, an understanding of performance metrics and the effect of clinical conditions, pharmacokinetics, and hemoglobin variants on hemoglobin A1c values need to be fully realized for optimal clinical utilization and reduced risk for complications.


Attendees of this webinar will:

  • Understand the clinical utility of Hemoglobin A1c testing and its role in the management of diabetes
  • Realize the governing guidelines for standardized measurement and assessment of Hemoglobin A1c
  • Identify critical factors that affect the analytical performance of Hemoglobin A1c methods
  • Recognize significant demographic and clinical factors affecting Hemoglobin A1c values

This program has been designated for 1.0 PACE continuing education credit.*

* There is a charge of $10.00 plus local tax for each half or full hour of CE credit. Purchase of CE credit is optional. Non-accredited participation in Siemens educational offerings and programs remains complimentary.

> Home
> Test Your System
> Help


           Corporate Information  |  Privacy Statement  |  Terms of Use